• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Ranbaxy Gets USFDA Nod for Gabapentin

      Posted AtNew Kerala

      Mohali-based pharma major Ranbaxy Laboratories has recevied the final approval from US Food and Drug Administration (USFDA) for manufacturing and marketing Gabapentin capsules of 100, 300 and 400 mg.

      Ranbaxy informed BSE today "The office of generic drugs, USFDA, has determined Ranbaxy formulations to be bio-equivalent and have the same therapeutic effect as that of the reference listed drug Neurontin capsules of Pfizer."Gabapentin is prescribed for the management of postherpetic neuralgia in adults, and as adjunctive therapy in the treatment of partial seizures with and without secondary generalisation in patients over 12 years of age with epilepsy. It is also prescribed as adjunctive therapy in the treatment of partial seizures in pediatric patients of age 3-12 years, the company release said.

      October 10, 2005


      Share this Article!

    Back to top^